Vertex Announces New Access Agreement with Scottish Government for ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor)
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that eligible cystic fibrosis patients living in Scotland will now have access to ORKAMBI ® (lumacaftor/ivacaftor) and SYMKEVI ® (tezacaftor/ivacaftor) in combination with ivacaftor following the signing of an access agreement.
“We would like to thank the Scottish authorities for their partnership and the collaborative and flexible way that we have worked together to find this access solution,” said Ludovic Fenaux, Senior Vice President, Vertex International. “It means that approximately 400 eligible cystic fibrosis patients in Scotland now have access to ORKAMBI or SYMKEVI.”
As part of the 5-year agreement Vertex has also committed to collecting real world data on these medicines that will support any future submissions to the Scottish Medicines Consortium (SMC).
Vertex cystic fibrosis medicines are reimbursed in 17 countries around the world including Austria, Australia, Denmark, Germany, the Republic of Ireland, Italy, the Netherlands, Sweden and the U.S.
About CF in Scotland
Approximately 900 people in Scotland live with CF. In the UK, the median age of death is 32 years. NHS Scotland estimates that one in 24 Scots have a CFTR mutation which, if carried by both parents, would lead to a child being born with CF.
About ORKAMBI® (lumacaftor/ivacaftor) and the F508del mutation
In people with two copies of the F508del mutation, the CFTR protein is not processed and trafficked normally within the cell, resulting in little-to-no CFTR protein at the cell surface. Patients with two copies of the F508del mutation are easily identified by a simple genetic test.
Lumacaftor/ivacaftor is a combination of lumacaftor, which is designed to increase the amount of mature protein at the cell surface by targeting the processing and trafficking defect of the F508del-CFTR protein, and ivacaftor, which is designed to enhance the function of the CFTR protein once it reaches the cell surface.
For complete product information, please see the Summary of Product Characteristics that can be found on www.ema.europa.eu.
About SYMKEVI® (tezacaftor/ivacaftor) in combination with ivacaftor
Some mutations result in CFTR protein that is not processed or folded normally within the cell, and that generally does not reach the cell surface. Tezacaftor is designed to address the trafficking and processing defect of the CFTR protein to enable it to reach the cell surface and ivacaftor is designed to enhance the function of the CFTR protein once it reaches the cell surface.
For complete product information, please see the Summary of Product Characteristics that can be found on www.ema.europa.eu.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has three approved medicines that treat the underlying cause of cystic fibrosis (CF) – a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational medicines in other serious diseases where it has deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha- 1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney diseases.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London, UK. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including nine consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes.
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, without limitation, the statements in the third paragraph of the press release. While Vertex believes the forward-looking statements contained in this press release are accurate, these forward-looking statements represent the company's beliefs only as of the date of this press release and there are a number of factors that could cause actual events or results to differ materially from those indicated by such forward-looking statements. Those risks and uncertainties include, among other things, that data from the company's development programs may not support registration or further development of its compounds due to safety, efficacy or other reasons, and other risks listed under Risk Factors in Vertex's annual report and quarterly reports filed with the Securities and Exchange Commission and available through the company's website at www.vrtx.com. Vertex disclaims any obligation to update the information contained in this press release as new information becomes available.
UK Media: +44 20 3204 5275
U.S. Media: 617-341-6992
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alpega TMS Shows Impressive Triple-digit Growth in Expanding SME Segment17.2.2020 18:00:00 EET | Press release
Alpega Group, the leading provider of cloud-based, end-to-end transportation and logistics management software in Europe, today announced that new business from its TMS software grew by 100% in the SME segment in 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200217005017/en/ Todd DeLaughter, Alpega Group CEO (Photo: Business Wire) Speaking on the results, Todd DeLaughter, Group CEO for Alpega said: “While the TMS market as a whole is growing in the high teens, we saw particular acceleration in the SME segment as more and more mid-size companies embrace technology to enable business efficiency and reduce cost while lowering carbon emissions. In 2019, we added 83 new clients for our TMS business.” “A big part of this success is down to the flexibility we offer our users. By bringing together the expertise of inet, Transwide and TenderEasy, Alpega TMS is able to cater to businesses dealing with all levels of logistics co
GSMA Board Statement on MWC Barcelona 202017.2.2020 18:00:00 EET | Press release
The GSMA Board would like to express its sadness at the unavoidable cancellation of MWC Barcelona 2020. This decision is painful, but we believe the correct one. Health and safety are the priorities of all of the GSMA Board and Mobile Network Operators. Our sincere thoughts are with those affected in China and around the world in these trying times. Our vision at the GSMA is to unlock the power of connectivity so that people, industry and society thrive. MWC is crucial to convene and advance the industry and mobile ecosystem. The mobile industry is committed to harnessing the power of mobile technology and connectivity to transform the lives of billions of people around the world, and we are committed to a great MWC Barcelona 2021. The Board thanks GSMA management and the Host City Parties for their hard work throughout this challenging and unprecedented situation. We look forward to working together again for an even better MWC Barcelona 2021. The GSMA Board is comprised of 25 of the
Mary Kay Inc. Announces Actress, Philanthropist Monique Coleman as First-Ever Pink Changing Lives Honoree17.2.2020 17:00:00 EET | Press release
Mary Kay Inc., a long-time leader in global female empowerment, is proud to announce Monique Coleman has been named the brand’s first-ever Pink Changing Lives Honoree. Pink Changing Lives—Mary Kay’s global commitment to celebrate the individuals and organizations that improve women’s and girls’ lives around the world—has supported more than three million women and their families by partnering with over 2,000 organizations and donating over $15 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200217005216/en/ Monique Coleman has been named Mary Kay Inc. first-ever Pink Changing Lives Honoree. (Photo: Mary Kay Inc.) Mary Kay’s Pink Changing Lives cause empowerment program donates funds to organizations focused on supporting cancer research, helping end hunger, protecting survivors from domestic abuse, beautifying communities, and many other programs empowering women and girls. In 2020, Mary Kay created the Pink Changing
ABS, the Royal Canadian Navy, and Defence Research & Development Canada Launch Digital Asset Framework Pilot17.2.2020 16:00:00 EET | Press release
ABS today announced it is engaged in a pilot program with the Royal Canadian Navy (RCN) and Defence Research and Development Canada (DRDC) to deliver the ABS Digital Asset Framework for the RCN’s Maritime Coastal Defence Vessels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200217005014/en/ The HCMS Saskatoon (Photo: Business Wire) The ABS Digital Asset Framework forms the foundation of a broader Conditioned-Based Class program that transforms ship classification from a calendar-based schedule to a condition-based model. The project, which will start with HMCS Saskatoon, will support the RCN’s larger Digital Navy Initiative. “ABS is a leader in delivering condition-based maintenance data services in maritime and offshore applications, and we are proud that the RCN have chosen to work with us on this landmark project,” said Christopher J. Wiernicki, ABS Chairman, President and CEO. “Through our digital programs for commerci
Oasis Is Proud to Announce the Availability of HELIOS 5G, its Latest Release of Secure UICC Operating System17.2.2020 14:15:00 EET | Press release
HELIOS 5G proposes enhanced security capabilities to secure critical communication services and respond actively to the greater range of possible threats associated with the wider variety of actors and devices types expected on the fifth generation of mobile network. Among many improvements implemented by Oasis R&D team, HELIOS 5G introduces new features to enable a device to authenticate to the 5G network with increased security and privacy of communications. The network authentication offered by Helios 5G is significantly stronger, due to longer crypto keys and an advanced algorithm. Additionally, the HELIOS OS benefits from a powerful onboard encryption including a SUCI calculator. It anonymizes the subscriber identity, thereby guaranteeing full subscriber privacy. Patrick Cao, Chief Operating Officer, said: “HELIOS 5G is an important milestone in the development history of our Helios SIM and eSIM Operating System. It demonstrates the expertise of our R&D team and confirms our posit
1.86 Customer Minutes Lost (CML) of Electricity per Year in Dubai17.2.2020 13:08:00 EET | Press release
Dubai Electricity and Water Authority (DEWA) has achieved a new world record in electricity Customer Minutes Lost (CML) per year. DEWA recorded 1.86 minutes, in Dubai, compared to around 15 minutes recorded by leading electricity companies in the European Union. This is a new addition to DEWA’s record of international achievements in electricity and water services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200217005093/en/ Dubai Electricity and Water Authority (DEWA) achieves a new world record in electricity Customer Minutes Lost (CML) per year and enhances Dubai’s prosperity. (Photo : AETOSWire). “At DEWA, we work according to the vision and directives of our leadership to provide a robust infrastructure according to the highest international standards. We continuously work to enhance the capacity and efficiency of transmission and distribution networks to provide electricity and water services according to the highes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom